Transdiagnostic Sleep and Circadian Treatment for Autistic Adolescents
- Sponsor
- Milton S. Hershey Medical Center
- Study ID
- NCT07612111
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Autism Spectrum Disorder
- Sleep
- Transdiagnostic
Eligibility Criteria
- Sex
- ALL
- Age
- 13 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Transdiagnostic Intervention for Sleep and Circadian Dysfunction — BEHAVIORALTransdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C). This evidence-based intervention targets psychosocial, behavioral, and cognitive processes that maintain sleep and circadian problems. The 4 Core Modules are: establishing regular sleep-wake times and routines; improving daytime functioning; correcting unhelpful sleep-related beliefs; and maintenance of behavior change. The optional Modules are: improving sleep efficiency; reducing time in bed; dealing with delayed or advanced phase; reducing sleep-related worry/vigilance; and negotiating sleep in a complicated environment and reducing nightmares. TranS-C consists of a total of 6, 50-min sessions over six weeks.
Study Details
Sleep and circadian problems are associated with deleterious social, emotional, and cognitive outcomes, yet are modifiable. This prospective study will adapt and optimize an empirically supported behavioral intervention that addresses common sleep and circadian problems of autistic adolescents, who are at increased risk for mental health disorders, using a transdiagnostic approach. The knowledge gained from this study will help to address a critical need for accessible transdiagnostic sleep interventions for autistic adolescents, who experience a broad range of sleep and circadian problems at high rates and often lack access to specialty care treatment.
Key Dates
- First listed
- May 28, 2026
- Start date
- Sep 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Sep 1, 2027
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 12 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Transdiagnostic Sleep and Circadian Intervention
Primary Outcome Measure
Multidimensional sleep health (MSH) score [ Time Frame: baseline (pretreatment) ]
Central Contacts
- Kristina P Lenker, PhD7175310003
Find similar trials
Related Studies
- Studying Childhood-onset Behavioral, Psychiatric, and Developmental DisordersRecruiting · National Institute of Mental Health (NIMH) · Bethesda, Maryland
- The Effects of Sleep on Human Microbiota: Implications for Health and DiseaseRecruiting · Mayo Clinic · Rochester, Minnesota
- Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)PHASE2 · Recruiting · Montefiore Medical Center · The Bronx, New York
- Cerebellar Stimulation and Cognitive ControlRecruiting · Krystal Parker, PhD · Iowa City, Iowa